KMPR — Kemper Corporation · 2026-09-11 · Verdict: WATCH · Conviction 3
Price $27.02 (screen price, universe_v2.csv generated 2026-09-11; no live quote) · Mkt cap $1.59B · EV ~$2.41B · EV/EBIT not meaningful for an insurer · P/GAAP book 0.73x · P/adjusted book 0.98x · Holdco net debt $814.5M · ADV $24.0M Sources read: 10-K 2026-02-11 (Items 1, 1A), 10-Q 2026-08-05 (MD&A), DEF 14A 2026-03-25, 8-Ks 2026-05-06 (Q1 results; credit facility), 2026-05-27 and 2026-07-21 (officers), 2026-08-05 (Q2 results, EX-99.1 and EX-99.2 investor supplement), Form 4s (12m). No transcript was filed; EX-99.2 is the closest SEC-sourced substitute.
Desk stats
- Revenue trend. FY2025 revenue $4,789.7M, +3.3% (universe_v2.csv, CY2025); P&C net written premiums $4,013.2M vs $3,837.0M on commercial auto +22.7% to $978.7M against flat personal auto (10-K 2025, Item 1). The latest quarter reverses it: revenues $1,092.7M, -10.8%, earned premiums -$119.2M (10-Q Q2'26). Volume, not price: policies in force -15.2% (EX-99.2, p9).
- Normalised after-tax profit. TTM (Q3'25-Q2'26) GAAP net loss attributable to Kemper -$495.5M. Add back, after tax: goodwill impairment +$460.0M; acquisition, disposition, integration and restructuring +$51.7M; investment impairments +$26.0M (including $16.6M of credit allowance on Reciprocal Exchange surplus notes); Non-Core Preferred run-off +$30.6M; change in fair value of equity and convertibles +$5.5M; less realised gains -$4.5M. Normalised $73.8M, $1.25/share, reconciling exactly to Kemper's own TTM Adjusted Consolidated Net Operating Income of $20.4 + $14.6 + $12.5 + $26.3 (EX-99.2, Segment Adjusted Operating Results). Already after tax, so no 25% notional rate applied. GAAP beside it: -$495.5M.
- EV / normalised after-tax profit. Market cap $1,592M plus debt $944.5M (10-Q) less $130.0M of cash held directly by Kemper and its non-insurance subsidiaries (EX-99.1, Capital) = EV $2,407M, 32.6x TTM, 22.9x on the Q2'26 run rate. This lens overstates the problem for a regulated insurer, since the debt sits at the holdco and the cash is trapped in subsidiaries; use the line below.
- Financial-lane metrics. P/E 21.6x on TTM normalised; price to GAAP book 0.73x ($37.22 BVPS); price to adjusted book 0.98x ($27.55, excluding goodwill, unrealised fixed-maturity losses and the life discount-rate effect); return on adjusted equity 4.5% ($73.8M over $1,628.8M average); adjusted book per share -11.2% ($27.55 vs $31.01); debt/equity 43.1% (EX-99.2, pp20-21).
- Is the growth sustainable? No, and deliberately so. California personal auto direct written premium is -23.1% and its policies in force fell 10.0% sequentially while rate is restored (EX-99.2, p11). The only growth is Florida/Texas personal auto (+7.0% PIF sequentially, 95.5% underlying combined ratio) and commercial auto (+9.2% PIF), whose underlying combined ratio has deteriorated five quarters running, 90.1% to 93.7%, with $17.7M of adverse prior-year development in Q2'26. No guidance given.
- What the screen got wrong. FINANCIALS.md passes KMPR on "tangible common BVPS +531.1%", from a prior-period equity tag of $370.0M in universe_v2.csv against the $2,953.4M Kemper reported at 30 June 2025 (EX-99.2, p21). The true figure is -11.2%. The 11.1x P/E and 12.1% ROTE both use CY2025 GAAP net income of $143.3M, a year that closed before the impairment; on normalised TTM earnings they are 21.6x and 4.5%. The row's one honest signal, net income -54.9%, was outvoted by the bad book tag.
1. What the business does
An insurance holding company with two segments (10-K 2025, Item 1). Specialty P&C, 89% of premiums, writes non-standard personal auto for drivers who cannot get preferred-risk cover, plus commercial auto for contractors and short-haul delivery, through about 17,800 independent agents in 22 states. Three states are 90% of it: California 63%, Florida 16%, Texas 11%. Life sells small home-service policies, average face $6,648, earning a steady $18M a quarter (EX-99.2, p13). A run-off Preferred P&C book and Kemper Reciprocal, an exchange Kemper manages for a fee of up to 30% of gross written premium, sit outside both.
2. Why it is mispriced — the edge case
Half an edge case. What is genuinely misread is the headline: a $464.8M second-quarter loss, $7.90 a share, that is 99% a non-cash goodwill write-off with, in the company's words, "no impact on the cash-generating ability of our businesses, statutory capital, holding company liquidity, or compliance with our debt and revolving credit covenants" (EX-99.1). The stock is down 49.9% over twelve months excluding the last month (universe_v2.csv) and screens as a loss-maker, which is what gets a name sold by quality and momentum mandates and skipped by earnings screens. Five insiders bought in the open market in August with zero sales, including new CEO Stephen McAnena (3,000 shares at $26.50), the CFO, the general counsel and two directors (Form 4s, 2026-08-11 to 08-13). Fuller & Thaler, a behavioural value manager, holds 6.3% (DEF 14A). What is not mispriced is the operating problem underneath. That caps this at WATCH.
3. Combined ratio and reserve development
Specialty P&C underlying combined ratio by quarter: 93.6%, 99.6%, 105.0%, 106.2%, 102.3% (EX-99.2, p22). Personal auto: 94.5%, 102.1%, 110.0%, 111.0%, 105.5%. The cause is named consistently, "higher claim severity and frequency primarily related to bodily injury coverages in California" (10-Q). Two things matter. The peak was Q1'26 and Q2'26 improved 5.5 points, with California's own underlying ratio falling 109.2% to 107.3% as rate earned in and a further 6.9% filing lodged. But more than half that gain was expenses, not losses: the expense ratio fell to 20.6% from 21.3% on $80M-plus of realised run-rate savings (EX-99.2, p14), while the underlying loss ratio is still 9.4 points worse than a year ago. The write-off reconciles in one line: goodwill $1,250.7M to $783.5M, a $467.2M non-deductible charge, $460.0M after tax, on the Specialty P&C reporting unit (8-K balance sheet; 10-Q, income taxes). It is a first, so genuinely non-recurring. The restructuring line is not: it has run every quarter since Q3'25 and management says it continues "through 2027" (10-Q). Nor is the Preferred run-off, negative four quarters straight. The live worry is reserves in commercial auto, the one line being grown: $17.7M adverse prior-year development in Q2'26 and an 18.7-point hit in Q3'25.
4. Balance sheet and capital allocation
$944.5M of debt: $398.1M 2.400% notes due 2030, $397.2M 3.800% due 2032, $149.2M 5.875% junior subordinated due 2062 (10-Q). Nothing matures before 2030, nothing is drawn on the revolver, but three items deserve attention. Kemper cut its own revolver from $600M to $350M effective 4 May 2026, framed as a fee saving (8-K 2026-05-06, Item 8.01), and the facility matures 15 March 2027, so it must be refinanced within six months. On 3 August 2026 the credit agreement was amended to replace the consolidated net worth covenant with a consolidated tangible net worth covenant and to add quarterly minimum risk-based capital covenants on the Trinity and United Insurance subsidiaries (10-Q) — a lender reacting to the write-off and reaching down to the operating companies. Third, holdco liquidity is thin: $130.0M of directly held cash and investments, and subsidiary capacity to pay dividends without regulatory approval estimated at $6.2M, against roughly $75M of annual common dividends and $40M of interest (10-Q, Subsidiary Dividends). Buybacks stopped: nothing in the first half of 2026 against $32.5M at $63.90 in the first half of 2025, with $304.2M unspent. All sixteen directors and officers together own 358,511 shares, under 1% (DEF 14A).
5. Management: said versus did
CEO of ten years Joseph Lacher separated in October 2025; the general counsel ran the company on an interim basis; McAnena became CEO on 1 June 2026, a new director with non-standard auto experience joined the same day, and the head of Kemper Auto was terminated without cause effective 3 August 2026 (DEF 14A; 8-Ks 2026-05-27, 2026-07-21). In May the interim CEO said Kemper was "taking decisive actions across underwriting, claims, and expense to return the business to profitability" (8-K 2026-05-06); one quarter later the underlying ratio had improved 3.9 points and $80M-plus of savings were banked, so the claim was met. Against that, the same release still showed 105.5% in personal auto, and McAnena's framing is appropriately cautious: "there is more work ahead" (EX-99.1).
6. Valuation
Reverse DCF: at $27.02 against $27.55 of adjusted book, the market pays 0.98x and so implies a sustainable return on adjusted equity equal to the cost of equity. At 10% on $1,623.1M that is about $162M a year, $2.75 a share, against $1.25 earned in the last twelve months and $3.83 in calendar 2025. The price implies Kemper recovers roughly 70% of its 2025 adjusted earnings and holds it on a premium base 15% smaller. - Bear, 30%, $18. California bodily injury severity does not stop, personal auto stalls above 103%, commercial auto reserves keep leaking, normalised earnings stay near $75M-$100M, and the board cuts the $0.32 dividend to protect a holdco with $6.2M of unrestricted subsidiary capacity. 0.65x adjusted book. - Base, 45%, $29. The 6.9% California filing and the July commercial auto increase earn in over four quarters, personal auto reaches roughly 100% underlying by mid-2027, the sub-20% expense target lands, Life holds $75M a year. Earnings $150M-$170M, $2.60-$2.90 a share, at 10x or 1.05x adjusted book. - Bull, 25%, $44. Underwriting returns to 2025's 93%-95% underlying ratio, Florida and Texas reach 40% of personal auto policies, the $304.2M authorisation is spent near book. Earnings $230M-$250M at 11x.
Probability weighted $29.45 against $27.02, about 9% upside. Not enough for an insurer whose loss ratio is still nine points worse than a year ago.
7. Catalysts and timeline
Q3 2026 results in early November: a third consecutive sequential improvement in the personal auto underlying ratio is the whole thesis. California action on the 6.9% filing and its earn-in through the first half of 2027. Refinancing of the revolver before 15 March 2027. Resumption of the buyback, which would signal the holdco considers itself liquid. A strategic plan from the new CEO.
8. Risks and pre-registered kill criteria
Concentration is the structural risk: California and Florida were 82% of personal auto gross written premium in 2025, and the 10-K states that "because of restrictions placed on the Company's ability to increase premium rates in certain states, including California, a pricing inadequacy may continue for a prolonged period" (Item 1A). 1. Specialty personal auto underlying combined ratio not below 100% for the quarter ending December 2026 (105.5% in Q2'26). 2. Adverse prior-year non-catastrophe development in commercial auto above $15M in any single quarter (Q2'26: $17.7M). 3. Any cut or suspension of the $0.32 quarterly dividend, or unrestricted subsidiary dividend capacity still below $50M in the next 10-K. 4. Specialty P&C policies in force still falling more than 10% year over year in the quarter ending June 2027 (-15.2% in Q2'26).
9. Verdict and summary
WATCH, conviction 3. Kemper is a $1.6B non-standard auto and home-service life insurer whose California personal auto book broke on bodily injury severity, taking the underlying combined ratio from 94.5% to a peak of 111.0% and forcing a $460M non-cash goodwill write-off that turned Q2 into a $7.90 per share loss and made the stock unownable for most screens. The write-off touched no cash, no statutory capital and no covenant, the underlying number has now improved two quarters running, $80M of run-rate savings landed, and five insiders including the new CEO bought in August with nobody selling. But the premium base is shrinking 15% a year by design, the loss ratio is still nine points worse than a year ago, commercial auto (the growing line) leaked reserves in two of the last four quarters, the holdco has $130M of cash against $6.2M of unrestricted subsidiary dividend capacity, and lenders have just tightened covenants down to the operating companies. At 0.98x adjusted book the market already assumes about 70% of the earnings come back, leaving roughly 9% of probability-weighted upside. The screen's 11.1x P/E and +531% book growth are both artefacts of stale and mis-tagged data. Revisit when personal auto prints an underlying combined ratio below 100%.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.